reaction of each sample in triplicate was run in the Applied Biosystems™ ViiA™ 7 system. The data were exported to Excel and fluorescence signal of each samples was plotted and a significant increase in slope corresponds to the melting temperature of the protein. UV/Vis absorbance spectroscopy. 5 µM ∆-1 was incubated with different concentrations of BSA in phosphate-buffered saline (PBS) buffer (4.3 mM Na 2 HPO 4 , 137 mM NaCl, 2.7 mM KCl, 1.4 mM KH 2 PO 4 , pH 7.4) for 6 h at 25 °C. The UV/Vis absorption spectra of ∆-1 was then recorded on a DR 6000™ UV VIS Spectrophotometer. Animal materials. In this study, the use of animals complied with the Guiding Principles in the Care and Use of Animals of the American Physiology Society and was approved by the Animal Care and Use Committee at the National Kaohsiung Medical University. Female BALB/cAnN.Cg-Foxn1 nu /CrlNarl (4-5 weeks) were purchased from BioLASCO Experimental Animal Center (Taiwan Co., Ltd). The mice were housed in Plexiglas cages in a temperature-controlled room (22 ± 1°C), on a 12 h/12 h light/dark schedule, and with free access to food and water. After one week, the mice were randomly divided into control and treatment groups. Western blotting. We homogenized the tumor tissues from control and treatment mice on ice for 10 s using a Polytron tissue homogenizer, and then lysed these tissues by PRO-PREP TM Protein extraction solution (iNtRON BIOTECHNOLOGY, USA). We determined the protein concentration in the supernatant by the bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL, USA). We separated equal amounts of proteins with SDS-PAGE, and then electro-transferred these proteins into a nitrocellulose membrane (PALL Life Science, Ann Arbor, MI, USA). We blocked the membrane for 1 h using 5% non-fat milk in TBST buffer. We incubated the membranes with corresponding primary antibodies. After washing twice with TBST buffer, we incubated the membranes with secondary antibodies against the corresponding primary antibodies, respectively. We visualized the signals with the chemiluminescence detection kit (Amersham, Piscataway, NJ, USA). The primary antibodies we used were: MEK, phosphorylation of MEK, ERK, phosphorylation of ERK, caspase 3, caspase 6, caspase 9, β-actin (Novus Biologicals, Littleton, CO, USA). Toxicity study in vivo. BALB/c mice were housed and administered a intraperitoneal (i.p.) injection of different concentrations of compounds (14-280 mg/kg) or vehicle (13 % DMSO) in 0.05 mL PBS until sacrifice at 21-day. The body weight and organ weight of each group were measured. The organ index was calculated by the endpoint of organ-to-body weight ratio. Statistical analysis. All data were presented as the mean ± standard error. For statistical analysis, all data were analyzed with one-way analysis of variance (ANOVA) followed by the Duncan's method for multiple comparisons. A significant difference was defined as p < 0.05. General experiment. Mass spectrometry was performed at the Mass Spectroscopy Unit at the Department of Chemistry, Hong Kong Baptist University, Hong Kong (China). Deuterated solvents for NMR purposes were obtained from Armar and used as received. 1 H and 13 C NMR were recorded on a Bruker Avance 400 spectrometer operating at 400 MHz ( 1 H) and 100 MHz ( 13 C). 1 The following abbreviations are used for convenience in reporting the multiplicity of NMR resonances: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. All NMR data were acquired and processed using standard Bruker software (Topspin).
Synthesis of compound 1 isomers.
Compounds Ʌ-(S)-S3 and ∆-(S)-S3 were synthesized using a modified literature method. 20 A suspension of dimer S1 (116 mg, 103 μmol), (S)-4-tert-butyl-2-(2-hydroxyphenyl)-2-oxazoline S2 (30.0 mg, 137 μmol), silver trifluoromethanesulfonate (81 mg, 315 μmol), and triethylamine (57 μL, 412 μmol) in dichloromethane (15 mL) was stirred at room temperature for 3 h. The suspension was filtered through a short plug of silica with hexane/ethyl acetate (1:2). The crude product was collected, concentrated to dryness; the residue was purified by silica gel column chromatography. The diastereomers could be well separated using hexane/ethyl acetate (3:1 to 2:1) as eluent. The resulting materials were dissolved in acetonitrile, washed five times with hexane, and concentrated to dryness to afford Λ-(S)-S3 as yellow solid (30 mg, 30%) and Δ-(S)-S3 as yellow solid (35.4 mg, 35%) with a dr of of at least 100:1 for both diastereomers. Because Ʌ-(S)-S3 and ∆-(S)-S3 were somewhat unstable during silica gel column chromatography, their 1 H NMR and 13 C NMR spectra could not be recorded. However, HRMS analysis indicated that the desired products had formed with sufficietn purity to be used in the next step without further purification. Compounds Ʌ-1 and ∆-1 were synthesized using a modified literature method 20 . Compound Ʌ-1: A suspension of Δ-(S)-S3 (30 mg, 40.1 μmol), 4,4'-dinonyl-2,2'-bipyridine (24.6 mg, 60.2 μmol), and trifluoroacetic acid (15 μL, 200 μmol) in acetonitrile (3.8 mL) was stirred at room temperature for 30 min. The reaction mixture was concentrated to dryness and subjected to silica gel chromatography with dichloromethane/methanol (20:1). The combined product eluents were again concentrated to dryness, and the resulting material was dissolved in a minimum amount of acetonitrile. The product was precipitated by the addition of a few drops of a saturated, aqueous solution of NH 4 PF 6 , and water (8 mL) was added. The yellow precipitate was collected by centrifugation, washed twice with water, and dried under high vacuum to afford Ʌ-1 as its PF 6 salt (20.0 mg, 46% Stability experiments. 5 mM compound 1 was stored in DMSO-d6/D2O (v/v = 9:1) at 298 K for 48 h, and 1 H NMR spectra were recorded. 1 H NMR experiments were carried out on a 400 MHz Bruker instrument. Additionally, 10 µM compound 1 was also stored in 80% acetonitrile/20% 20 mM Tris-HCl (20 mM NaCl, pH 7.4) buffer or cell culture DMEM medium for 48 h. Absorption spectra were recorded on Cary UV-100 Spectrophotometer. The absorbance of compound 1 in Tris-HCl buffer or culture medium was corrected by subtraction of the background absorbance. . ICP-MS assay for mitochondrial, nuclear and whole cell lysate iridium accumulation. A498 cells were treated with racemic 1, Ʌ-1 or ∆-1 (5 μM) for 6 h and the cells were harvested by trypsinization and appropriate organelle isolation procedures performed. Cytosol fraction 1 was the isolate from the the separation of mitochondria. Cytosol fraction 2 was cytoplasmic extract from the nuclear protein extraction. The iridium counts were normalized to protein concentration of indicated organelles, which was determined by a BCA assay. 
